Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Residual Disease”

1,347 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,347 results

Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Post-approval studies (Phase 4)Study completedNCT00611806
What this trial is testing

Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Not applicableStudy completedNCT01924572
What this trial is testing

Placental Transfusion in Term Infants: A Pilot Study

Who this might be right for
Anemia
University of Rhode Island 32
Not applicableNot Yet RecruitingNCT07254156
What this trial is testing

Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer

Who this might be right for
Colorectal CancerMRDctDNA
Sun Yat-sen University 229
Post-approval studies (Phase 4)Not Yet RecruitingNCT07584369
What this trial is testing

Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study

Who this might be right for
HIV -1 InfectionMethamphetamine Use
University of California, San Francisco 20
Large-scale testing (Phase 3)Study completedNCT04642469
What this trial is testing

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Who this might be right for
Carcinoma, Non- Small Cell Lung
AstraZeneca 30
Testing effectiveness (Phase 2)Looking for participantsNCT05536505
What this trial is testing

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

Who this might be right for
MRD
Guangdong Association of Clinical Trials 180
Not applicableLooking for participantsNCT07665931
What this trial is testing

Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Hyperinflation
Azienda Socio Sanitaria Territoriale di Lodi 23
Not applicableNot Yet RecruitingNCT07438795
What this trial is testing

Post-Amputation Stump Infection as a Predictor of Persistent Residual Limb Pain: A Prospective Cohort Study

Who this might be right for
Residual Limb PainStump PainPost-Amputation Pain+2 more
Ukrainian Society of Regional Anesthesia and Pain Therapy 150
Early research (Phase 1)Study completedNCT00050050
What this trial is testing

Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Massachusetts General Hospital 40
Not applicableUnknownNCT06182917
What this trial is testing

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
West China Second University Hospital 35
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Not applicableNot Yet RecruitingNCT07443592
What this trial is testing

Treatment for Ph-negative ALL for Adults up to 65 Years

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 330
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Large-scale testing (Phase 3)Looking for participantsNCT06932471
What this trial is testing

Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Wuhan Createrna Science and Technology Co., Ltd 20
Not applicableLooking for participantsNCT06963307
What this trial is testing

Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
JaxBio Ltd 300
Testing effectiveness (Phase 2)Looking for participantsNCT04966663
What this trial is testing

Using ctDNA to Determine Therapies for Lung Cancer

Who this might be right for
Non Small Cell Lung CancerComplete Surgical ResectionCirculating Tumor DNA
University Health Network, Toronto 66
Next Page